InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P21
Within normal range
vs 2Y Ago
-2.7x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -43.92% |
| Q3 2025 | -26.07% |
| Q2 2025 | -7.17% |
| Q1 2025 | 33.68% |
| Q4 2024 | -36.97% |
| Q3 2024 | -77.50% |
| Q2 2024 | 46.79% |
| Q1 2024 | -5.91% |
| Q4 2023 | 15.99% |
| Q3 2023 | -142.58% |
| Q2 2023 | 45.83% |
| Q1 2023 | 39.01% |
| Q4 2022 | -20.29% |
| Q3 2022 | 43.46% |
| Q2 2022 | 24.41% |
| Q1 2022 | -47.92% |
| Q4 2021 | -34.45% |
| Q3 2021 | -20.67% |
| Q2 2021 | 52.31% |
| Q1 2021 | -156.01% |
| Q4 2020 | -31.33% |
| Q3 2020 | -10.43% |
| Q2 2020 | 16.06% |
| Q1 2020 | 28.47% |
| Q4 2019 | 13.50% |
| Q3 2019 | -24.00% |
| Q2 2019 | 9.99% |
| Q1 2019 | -64.78% |
| Q4 2018 | 2.58% |
| Q3 2018 | -34.46% |
| Q2 2018 | -44.20% |
| Q1 2018 | 16.27% |
| Q4 2017 | 24.68% |
| Q3 2017 | -31.10% |
| Q2 2017 | -11.27% |
| Q1 2017 | -17.06% |
| Q4 2016 | -287.43% |
| Q3 2016 | -141.88% |
| Q2 2016 | 21.64% |
| Q1 2016 | 15.88% |